J. Moon

J. Cheong, S. Kim, Jin Seok Kim, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement

Jae Hyun Kim, H. Song, Y. Do, 2013, Cancer research and treatment : official journal of Korean Cancer Association.

Absolute lymphocyte count at day + 21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone

Je-Jung Lee, Y. Chae, S. Sohn, 2012, Leukemia & lymphoma.

Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population.

Sung-Soo Yoon, Y. Lee, Y. Koh, 2018, Leukemia research.

Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia

J. Lipton, C. Jung, Hyeoung-Joon Kim, 2016, Journal of Translational Medicine.

Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review

Y. Chae, S. Sohn, Soo Jung Lee, 2009, International journal of hematology.

Clonal hematopoiesis is associated with risk of severe Covid-19

P. Awadalla, M. Ladanyi, M. Berger, 2020, Nature Communications.

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Jinny Park, J. H. Lee, Young-Uk Cho, 2013 .

Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP

Y. Chae, S. Sohn, Su Jeong Lee, 2010, Cancer Chemotherapy and Pharmacology.

Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): An open-label phase 1/2 trial.

H. Yhim, Y. Koh, J. Moon, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients.

H. Eom, C. Suh, S. S. Yoon, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Association of Vascular Endothelial Growth Factor Gene Polymorphisms with Susceptibility and Clinicopathologic Characteristics of Colorectal Cancer

J. Park, G. Choi, Y. Cho, 2008, Journal of Korean medical science.

Investigation of Vascular Endothelial Growth Factor Gene Polymorphisms and Its Association with Clinicopathologic Characteristics in Gastric Cancer

H. Chung, J. Park, H. Bae, 2007, Oncology.

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia

Hee-Jin Kim, Sun-Hee Kim, H. Won, 2018, Leukemia.

Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment

Sung-Soo Yoon, Y. Do, Je-Jung Lee, 2012, Annals of Hematology.

A Multi-Center International Survey Related to the Nutritional Support after Hematopoietic Stem Cell Transplantation Endorsed by the ASIA Pacific Blood and Marrow Transplantation (APBMT) *

N. Linton, Y. Kodera, R. Suzuki, 2012 .

Simple tests to predict hepatic fibrosis in nonalcoholic chronic liver diseases.

S. Jun, Kyoung-Oh Kim, Jong Hyeok Kim, 2007, Gut and liver.

Identification of a novel HLA-B*15 variant, B*15:367, using sequence-based typing in a Korean woman.

J. Moon, J. Ham, D. Won, 2015, Tissue antigens.

Application of CIBMTR risk score to NIH chronic GVHD at individual centers.

B. Storer, J. Lipton, J. Kuruvilla, 2014, Blood.

Light and shade of ruxolitinib: positive role of early treatment with ruxolitinib and ruxolitinib withdrawal syndrome in patients with myelofibrosis

S. Sohn, Jung Min Lee, J. Moon, 2022, Expert review of hematology.

Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload

Il-Hwan Kim, S. Sohn, Gyeong-Won Lee, 2015, Transfusion.

Chemotherapy adherence is a favorable prognostic factor for elderly patients with multiple myeloma who are treated with a frontline bortezomib-containing regimen

J. Lee, Y. Lee, Sung hyun Kim, 2018, Yeungnam University journal of medicine.

Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine

G. Choi, M. Jung, S. Jeon, 2011, Medical oncology.

Hydroxymethylcytosine correlates with epigenetic regulatory mutations , but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2017 .

Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype

M. Minden, S. Ogawa, Namshin Kim, 2015, Haematologica.

Survey of expert opinions and related recommendations regarding bridging therapy using hypomethylating agents followed by allogeneic transplantation for high-risk MDS.

S. Sohn, J. Moon, 2015, Critical reviews in oncology/hematology.

Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment

Y. Chae, S. Sohn, D. Jo, 2010, Annals of Hematology.

Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS working party.

J. H. Lee, J. Cheong, Hyeoung-Joon Kim, 2017, Oncotarget.

Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast

Y. Lee, Y. Chae, S. Sohn, 2012, Annals of Hematology.

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2020, Leukemia & lymphoma.

Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group

A. Cheng, Y. Kwong, S. Kim, 2012, Leukemia & lymphoma.

Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant

M. Minden, C. Jung, Je-Jung Lee, 2015, Annals of Hematology.

Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia

W. Lee, B. Ye, J. Moon, 2013, Annals of Hematology.

Pre-Emptive Treatment with Nilotinib after Second Allogeneic Transplantation in a Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patient with High Risk of Relapse

Y. Chae, S. Sohn, Jong Gwang Kim, 2010, Acta Haematologica.

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients.

H. W. Lee, Y. Kim, H. Ryoo, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia

Jinny Park, J. Cheong, Y. Min, 2011, Leukemia & lymphoma.

Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients

Jinny Park, J. H. Lee, J. Cheong, 2014, International Journal of Hematology.

Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD

J. Lipton, J. Kuruvilla, Vikas Gupta, 2017, Annals of Hematology.

Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, EJHaem.

The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma

Y. Seol, Gyeong-Won Lee, Kyung-Hwa Shin, 2010, The Korean journal of hematology.

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD

H. Yhim, Hyeoung-Joon Kim, S. Sohn, 2022, Cell transplantation.

Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation

Yunsuk Choi, Taeyun Kim, W. Lee, 2019, The Korean journal of internal medicine.

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia

Zhaolei Zhang, C. Jung, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

Y. Lee, Je-Jung Lee, Hyeoung-Joon Kim, 2018, Clinical lymphoma, myeloma & leukemia.

KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement

Hee-Jin Kim, Sun-Hee Kim, Jinny Park, 2012, Annals of Hematology.

Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.

S. Sohn, D. H. Kim, Jong Gwang Kim, 2005, Japanese journal of clinical oncology.

Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors

Ji Yeon Lee, Y. Koh, P. G. Choe, 2022, Haematologica.

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)

Kihyun Kim, Jin Seok Kim, H. Eom, 2022, Frontiers in Oncology.

Current status and future directions of clinical research and practice in adult acute lymphoblastic leukemia patients in Korea

Y. Joo, Dae-Young Kim, J. Moon, 2014, Blood research.

Clinical Significance of Autoantibody Expression in Allogeneic Stem-Cell Recipients

Soo-Jung Lee, Y. Chae, S. Sohn, 2009, Transplantation.

Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients

J. H. Lee, V. Voelter, Kihyun Kim, 2013, Annals of Hematology.

A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2012, Annals of Hematology.

Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo‐HCT: 12‐year follow‐up data

J. Lipton, A. Viswabandya, S. Sohn, 2017, European journal of haematology.

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2

Y. Chae, S. Sohn, H. Kim, 2007, Bone Marrow Transplantation.

Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.

J. Lipton, J. Kuruvilla, Vikas Gupta, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adoptable strategic approaches to improve outcomes of allogeneic peripheral blood stem cell transplantations from unrelated donors

S. Sohn, J. Moon, 2014, Transfusion.

Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.

J. Cheong, Sung-Soo Yoon, Jin Seok Kim, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation

S. Sohn, J. Moon, Sang-Yong Shin, 2015, The Korean journal of internal medicine.

Comparable Analysis of Outcomes for Allogeneic Peripheral Blood Stem Cell Transplantation from Matched Related and Matched Unrelated Donors in Acute Myeloid Leukemia

H. Eom, Hyeoung-Joon Kim, Y. Chae, 2011, Acta Haematologica.

Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors

H. Eom, Hyeoung-Joon Kim, Y. Chae, 2010, Annals of Hematology.

Clinical Efficacy of Mitoxantrone and Ara-C with or without Etoposide Salvage Chemotherapy in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Retrospective Multicenter Study of the Korean Adult ALL Working Party

Je-Jung Lee, S. Sohn, D. Jo, 2014, Acta Haematologica.

Association of Vascular Endothelial Growth Factor Gene Polymorphisms with Susceptibility and Clinicopathologic Characteristics of Colorectal Cancer

J. Park, G. Choi, Y. Cho, 2008, Journal of Korean medical science.

Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML

Y. Lee, Y. Chae, Jun Young Choi, 2011, Chonnam medical journal.

Impact of Day +11 Methotrexate on the Incidence of Graft-versus-host Disease after HLA-identical Allogeneic Peripheral Blood Stem Cell Transplantation

Y. Cho, Y. Chae, S. Sohn, 2006 .

Clinical characteristics and prognostic factors of acquired haemophilia A in Korea

Sung-Soo Yoon, Jin Seok Kim, Y. Do, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

COVID-19 transmission and blood transfusion: A case report

S. Sohn, J. Moon, J. Suh, 2020, Journal of Infection and Public Health.

No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer.

H. Chung, S. Jeon, Y. Chae, 2009, Japanese journal of clinical oncology.

Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset

S. Sohn, H. Shin, J. Moon, 2010, Bone Marrow Transplantation.

The role of percutaneous transhepatic papillary balloon dilation in percutaneous choledochoscopic lithotomy.

J. S. Lee, M. S. Lee, C. Shim, 2001, Gastrointestinal endoscopy.

VARS2 V552V variant as prognostic marker in patients with early breast cancer

Sang Kyun Sohn, Ho Yong Park, Ji Young Park, 2011, Medical oncology.

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.

Jong-Ho Won, Sang Kyun Sohn, Sung-Hoon Jung, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hypomethylating agent-based post-transplant strategies to maximize the outcome of high-risk acute myeloid leukemia after allogeneic stem cell transplantation

S. Sohn, J. Moon, D. Baek, 2020, Expert review of hematology.

Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category

J. Huh, Hyeoung-Joon Kim, S. Sohn, 2013, Genes, chromosomes & cancer.

Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia

J. Lipton, C. Jung, Hyeoung-Joon Kim, 2016, Journal of Translational Medicine.

Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesis

Hogune Im, S. Yoon, Inkyung Jung, 2021, bioRxiv.

Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.

Jinny Park, C. Jung, Y. Mun, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Significance of Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway in Korean Patients with Colorectal Cancer

G. Choi, S. Jeon, Y. Chae, 2011, Oncology.

BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients.

Kihyun Kim, C. Jung, S. Sohn, 2010, Leukemia research.

Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma

Seong-Jang Kim, S. Jeong, Je-Jung Lee, 2013, Cancer science.

Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia

Hee-Jin Kim, Sun-Hee Kim, J. Huh, 2011, Annals of Hematology.

A genome‐wide single‐nucleotide polymorphism‐array can improve the prognostic stratification of the core binding factor acute myeloid leukemia

Sun-Hee Kim, Jinny Park, Y. Mun, 2012, American journal of hematology.

Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma

S. Sohn, J. Moon, D. Baek, 2020, Blood research.

Endoscopic Submucosal Resection with Double Ligation Technique for Treatment of Small Rectal Carcinoid Tumors

C. Park, J. Moon, W. Shin, 2006, Endoscopy.

A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea

Jinny Park, J. Cheong, C. Jung, 2018, Cancer medicine.

Mobilization effects of G‐CSF, GM‐CSF, and darbepoetin‐α for allogeneic peripheral blood stem cell transplantation

Y. Lee, Y. Cho, Y. Chae, 2009, Journal of clinical apheresis.

Severe congenital neutropenia mimicking chronic idiopathic neutropenia: a case report

S. Sohn, J. Moon, Soyoon Hwang, 2022, Journal of Yeungnam medical science.

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Angela G. Fleischman, A. Salar, S. Verstovsek, 2023, The Lancet.

Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV‐seropositive recipients and donors

Je-Jung Lee, Y. Cho, Hyeoung-Joon Kim, 2008, American journal of hematology.

Role of thymoglobulin in matched sibling allogeneic hematopoietic stem cell transplantation with busulfan and fludarabine conditioning in myeloid malignanicies

S. Park, H. S. Lee, I. Song, 2018, Bone Marrow Transplantation.

Clonal hematopoiesis is associated with risk of severe Covid-19

P. Awadalla, M. Ladanyi, M. Berger, 2021, Nature communications.

Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients

Y. Chae, S. Sohn, J. Moon, 2009, Bone Marrow Transplantation.

Rapid Helper T-Cell Recovery at 3 Months Correlates to Successful Transplant Outcomes after Allogeneic Stem Cell Transplantation.

S. Sohn, D. H. Kim, Jong Gwang Kim, 2005 .

Patients presenting high fever with lymphadenopathy after COVID-19 vaccination were diagnosed with hemophagocytic lymphohistiocytosis

J. Jeong, S. Sohn, Jung Min Lee, 2021, Infectious diseases.

New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients

Y. Lee, S. Sohn, J. Moon, 2016, The Korean journal of internal medicine.

Variable Number of Tandem Repeats (VNTR) Disparity between Donor and Recipient has a Potential to Predict the Outcomes of HLA-identical Allogeneic Stem Cell Transplantation

N. Lee, Y. Chae, S. Sohn, 2005 .

Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors

J. Cheong, Y. Koh, Yeonjoo Choi, 2018, Annals of Hematology.

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients

J. Cheong, Y. Min, C. Jung, 2012, Medical Oncology.

Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions

S. Sohn, Jung Min Lee, J. Moon, 2021, Expert review of hematology.

Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia

S. Sohn, Jung Min Lee, J. Moon, 2021, Expert review of hematology.

Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia

C. Jung, Sung-Soo Yoon, S. Kim, 2013, Annals of Hematology.

Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia

J. Lee, Yunsuk Choi, Y. Do, 2020, Yonsei medical journal.

Salvage treatments with all-trans retinoic acid and arsenic trioxide-based regimens in acute promyelocytic leukemia

Y. Cho, Y. Chae, S. Sohn, 2008 .

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Marc S. Tyndel, Zhaolei Zhang, Y. Lee, 2018, Blood.

A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.

H. Won, J. Lipton, Jong-Won Kim, 2011, Blood.

Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II study.

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2010, Clinical lymphoma, myeloma & leukemia.

Prognostic Impact of Polymorphisms in the CASPASE Genes on Survival of Patients with Colorectal Cancer

G. Choi, M. Jung, S. Jeon, 2012, Cancer research and treatment : official journal of Korean Cancer Association.

Clinical Significance of Autoantibody Expression in Allogeneic Stem Cell Recipients.

Y. Chae, S. Sohn, K. Lee, 2008 .

Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma

Kihyun Kim, J. Lee, J. Jo, 2022, International Journal of Hematology.

Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD

S. Sohn, Jung Min Lee, J. Moon, 2019, Blood research.

Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome‐positive acute lymphoblastic leukemia

S. Yun, C. Jung, M. K. Kim, 2015, American journal of hematology.

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.

Jinny Park, Young-Uk Cho, Kihyun Kim, 2015, Blood.

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

Je-Jung Lee, Hyeoung-Joon Kim, S. Sohn, 2010, Annals of Hematology.

Characterization of the novel DQA1*01:01:09 allele by next‐generation sequencing

J. Moon, J. Ham, D. Won, 2021, HLA.

Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate

Y. Lee, S. Sohn, J. Moon, 2013, International Journal of Hematology.

Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study

Kihyun Kim, Sung-Soo Yoon, H. Kang, 2016, Cancer medicine.

Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia

Junshik Hong, C. Jung, Sung-Soo Yoon, 2020, Journal of clinical medicine.

Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma

S. Kim, Y. Lee, J. Jo, 2019, Bone Marrow Transplantation.

The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma

Kihyun Kim, Sung-Soo Yoon, Y. Do, 2018, Acta Haematologica.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2017, Oncotarget.

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation

Junshik Hong, S. Kim, Jin Seok Kim, 2015, Annals of Hematology.

Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome

J. Cheong, Y. Min, C. Jung, 2015, Acta Haematologica.

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2020, Bone Marrow Transplantation.

Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406/1407 study

Yunsuk Choi, H. Yhim, S. Sohn, 2021, The Korean journal of internal medicine.

Single Center Experience of Allogeneic Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia

S. Sohn, K. Lee, J. Moon, 2004 .

MGMT −535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy

Sang Kyun Sohn, Joon Ho Moon, G. Choi, 2010, Journal of Cancer Research and Clinical Oncology.

No association of the hypoxia-inducible factor-1α gene polymorphisms with survival in patients with colorectal cancer

Jin Young Park, G. Choi, Y. Chae, 2011, Medical oncology.

No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer

G. Choi, S. Jeon, Y. Cho, 2011, Cancer research and treatment : official journal of Korean Cancer Association.

Follow-up result of endoscopic mucosal resection for gastric adenoma and early gastric cancer

Choong Kee Park, Jong-Hyeok Kim, W. Shin, 2006 .

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores

Y. Won, H. Kang, Jin Seok Kim, 2017, Annals of Hematology.

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy

Kihyun Kim, H. Kang, Jin Seok Kim, 2017, American journal of hematology.

Vascular Endothelial Growth Factor Gene Polymorphisms Associated with Prognosis for Patients with Colorectal Cancer

J. Park, G. Choi, Y. Cho, 2008, Clinical Cancer Research.

IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer.

J. Y. Park, G. Choi, Y. Chae, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

IVS 10 1 12 A > G polymorphism in hMSH 2 gene associated with prognosis for patients with colorectal cancer

J. Y. Park, G. Choi, Y. Chae, 2010 .

Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer

Jin Young Park, G. Choi, S. Jeon, 2009, Journal of Cancer Research and Clinical Oncology.

The 2016 APBMT Activity Survey Report: Trends in haploidentical and cord blood transplantation in the Asia-Pacific region.

B. Ko, J. Sim, A. Srivastava, 2021, Blood cell therapy.

Trends in disease indications for hematopoietic stem cell transplantation in the Asia-Pacific region: A report of the Activity Survey 2017 from APBMT

B. Ko, J. Sim, A. Srivastava, 2022, Blood cell therapy.

[A case of adenosquamous carcinoma of the papilla of Vater].

Kyoung-Oh Kim, Jong Hyeok Kim, Choong Kee Park, 2006, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer

G. Choi, Y. Chae, S. Sohn, 2011, Medical oncology.

Genome‐wide genotype‐based risk model for survival in acute myeloid leukaemia patients with normal karyotype

Zhaolei Zhang, Jinny Park, E. Shin, 2013, British journal of haematology.

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party

J. H. Lee, Kihyun Kim, S. Yoon, 2022, Blood Cancer Journal.

Cyclin D1 Overexpression, p16 Loss, and pRb Inactivation Play a Key Role in Pulmonary Carcinogenesis and have a Prognostic Implication for the long-term Survival in Non-small Cell Lung Carcinoma Patients

H. Bae, Y. Chae, S. Sohn, 2009 .

Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience

J. Cheong, Y. Min, Sung-Soo Yoon, 2017, Annals of Hematology.

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

J. Choi, Sungeun Kim, J. Lee, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma

J. Min, Y. Do, S. Kweon, 2015, BMC Cancer.

Outpatient-basis Chemotherapy of Oxaliplatin, 5-fluorouracil, and Leucovorin as First-line Treatment for Patients with Metastatic or Recurrent Colorectal Cancer

G. Choi, Y. Cho, Y. Chae, 2007, Journal of Korean medical science.

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

S. Kim, Jin Seok Kim, Y. Do, 2020, Scientific Reports.

The clonal origins of leukemic progression of myelodysplasia

S. Y. Kim, Marc S. Tyndel, Zhaolei Zhang, 2016, Leukemia.

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

M. Minden, C. Jung, Je-Jung Lee, 2016, Oncotarget.

Clinical impact of spine magnetic resonance imaging as a valuable prognostic tool for patients with multiple myeloma: a retrospective study

S. Sohn, Jung Min Lee, J. Moon, 2022, Journal of Yeungnam Medical Science.

RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection

H. Bae, Y. Chae, S. Sohn, 2011, Journal of Cancer Research and Clinical Oncology.

Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2016, Annals of Hematology.

Plasma cell myeloma initially diagnosed as light-chain deposition disease on liver biopsy: A case report and literature review

Jae Hyun Kim, S. Cho, A. Seo, 2023, Medicine.

Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin

G. Choi, S. Jeon, Y. Chae, 2009, Cancer Chemotherapy and Pharmacology.

RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia

Marc S. Tyndel, Zhaolei Zhang, J. Cheong, 2020, Scientific Reports.

Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy

Y. Lee, Y. Chae, S. Sohn, 2014, The Korean journal of internal medicine.

Gallbladder lymphangioma: a case report and review of the literature.

K. H. Park, Jwa-Kyung Kim, Kyoung-Oh Kim, 2007, World journal of gastroenterology.

Oral Camostat for Prevention of Post-ERCP Pancreatitis: A Pilot Study

Kyoung-Oh Kim, Jong Hyeok Kim, Choong Kee Park, 2006 .

Favorable effects of low-dose anti-thymocyte globulin in a partially-mismatched HLA group in an unrelated allogeneic stem cell transplantation setting.

S. Sohn, J. Moon, 2015, Annals of Transplantation.

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype

Zhaolei Zhang, C. Jung, Y. Lee, 2017, Oncotarget.

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2023, Cancer research and treatment : official journal of Korean Cancer Association.

Efficacy of dose escalation of imatinib mesylate in patients with cytogenetic or hematologic resistance

Y. Cho, Y. Chae, S. Sohn, 2007, Leukemia & lymphoma.

IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer.

J. Y. Park, G. Choi, Y. Chae, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study

H. Eom, Y. Lee, S. Sohn, 2023, The Korean journal of internal medicine.

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).

Kihyun Kim, H. Kang, Jin Seok Kim, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation

K. Yoo, S. Kim, H. Eom, 2023, Blood cancer journal.

Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group

A. Cheng, Y. Kwong, S. Kim, 2012, Leukemia & lymphoma.

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia

J. Cheong, Jae-Sook Ahn, J. Moon, 2024, Scientific reports.

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma

Y. Lee, J. Jo, Y. Do, 2023, The Korean journal of internal medicine.

Different characteristics identified by single nucleotide polymorphism array analysis in leukemia suggest the need for different application strategies depending on disease category

J. Huh, Hyeoung-Joon Kim, S. Sohn, 2012, Genes, chromosomes & cancer.

[Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].

S. Jun, Kyoung-Oh Kim, Jong Hyeok Kim, 2006, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

Highly Aggressive de novo Aleukemic Variant of Mast Cell Leukemia Without KIT D816V Mutation

J. Moon, J. Ham, J. Suh, 2017, Annals of laboratory medicine.